Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07387367
What this trial is testing

Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

Who this might be right for
Adenovirus Infections
SymBio Pharmaceuticals 180
Post-approval studies (Phase 4)UnknownNCT04636918
What this trial is testing

Ikervis for DED Due to GVHD Post Allo-HSCT

Who this might be right for
Leukemia (Both ALL and AML)MDS-EB-1
Singapore Eye Research Institute 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07261215
What this trial is testing

Zuberitamab for EBV Infection Post-Allo-HSCT

Who this might be right for
HSCTEBV Infection
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)UnknownNCT03530085
What this trial is testing

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning+1 more
Nanfang Hospital, Southern Medical University 60
Early research (Phase 1)Looking for participantsNCT06440135
What this trial is testing

Ziftomenib Maintenance Post Allo-HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionNPM1 Mutation+1 more
Massachusetts General Hospital 22
Not applicableUnknownNCT02850822
What this trial is testing

Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeChemotherapy
Nanfang Hospital, Southern Medical University 250
Large-scale testing (Phase 3)Study completedNCT00774527
What this trial is testing

Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT

Who this might be right for
Bone Marrow Failure Syndromes
Cooperative Study Group A for Hematology 82
Large-scale testing (Phase 3)Not Yet RecruitingNCT05907499
What this trial is testing

Decitabine for Poor Graft Function Post Allo-HSCT

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 76
Testing effectiveness (Phase 2)UnknownNCT05598593
What this trial is testing

Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

Who this might be right for
Cytarabine+Thiotepa + Fludarabine + BusulfanT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 70
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Not applicableApproved For MarketingNCT03147742
What this trial is testing

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Early research (Phase 1)Looking for participantsNCT07280494
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Who this might be right for
CD7+ T-ALL/LBL
Peking University People's Hospital 18
Large-scale testing (Phase 3)UnknownNCT01955772
What this trial is testing

Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.

Who this might be right for
Myeloablative Allo-SCT
University Hospital, Clermont-Ferrand 240
Testing effectiveness (Phase 2)Looking for participantsNCT06447090
What this trial is testing

VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT

Who this might be right for
Relapse Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT05669079
What this trial is testing

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 100
Not applicableUnknownNCT06177561
What this trial is testing

Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT

Who this might be right for
Leukemia
Ruijin Hospital 38
Very early researchLooking for participantsNCT07126782
What this trial is testing

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)AML
Institute of Hematology & Blood Diseases Hospital, China 10
Large-scale testing (Phase 3)Study completedNCT02634294
What this trial is testing

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematological NeoplasmsRecurrence
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT05858814
What this trial is testing

RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia
Guangdong Ruishun Biotech Co., Ltd 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598384
What this trial is testing

VA as Maintenance Therapy Post Allo-HSCT in MDS and AML

Who this might be right for
Acute Myeloid Leukemia
Navy General Hospital, Beijing 40
Next Page